[ <sup>18</sup>F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study.

Chan DL, Hayes A, Karfis I, Conner A, Mileva M, Bernard E, Navalkissoor S, Gnanasekaran G, Clarke SJ, Roach PJ, Flamen P, Caplin ME, Pavlakis N, Toumpanakis C, Bailey DL